Clinical Management of Adult Coronavirus Infection Disease 2019 (COVID-19) Positive in the Setting of Low and Medium Intensity of Care: a Short Practical Review-Reference-Cited by-同舟云学术

Clinical Management of Adult Coronavirus Infection Disease 2019 (COVID-19) Positive in the Setting of Low and Medium Intensity of Care: a Short Practical Review

Published:2020-05-29 Issue:6 Volume:2 Page:694-699
ISSN:2523-8973
Container-title:SN Comprehensive Clinical Medicine
language:en
Short-container-title:SN Compr. Clin. Med.

Author:

Pennica Alfredo^ORCID,Conforti Giulia^ORCID,Falangone Francesca^ORCID,Martocchia Antonio^ORCID,Tafaro Laura^ORCID,Sentimentale Alberto^ORCID,Marini Valentina^ORCID,Pezzuto Aldo^ORCID,Spuntarelli Valerio^ORCID,Martelletti Paolo^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s42399-020-00333-w.pdf

Reference30 articles.

1. Coranavirus Resource Center at John Hopkins University & Medicine. Last accessed 15 May 2020. https://coronavirus.jhu.edu/map.html

2. World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: interim guidance. 2020. WHO/nCoV/Clinical/2020.3

3. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239–42. https://doi.org/10.1001/jama.2020.2648.

4. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.

5. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–13.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 and SARS-CoV-2 Vaccines: A Cameo Role for Headache;International Journal of Environmental Research and Public Health;2023-02-22

2. Evaluation of adverse events of bamlanivimab, bamlanivimab/etesevimab used for COVID-19 based on FAERS database;Expert Opinion on Drug Safety;2022-10-06

3. Coronavirus 2019 disease: Are corticosteroids the key treatment? A retrospective case-control study in Brazil;Annals of Medicine & Surgery;2022-10

4. Clinical laboratory parameters and comorbidities associated with severity of coronavirus disease 2019 (COVID-19) in Kurdistan Region of Iraq;Practical Laboratory Medicine;2022-08

5. The detrimental impact of elevated Ferritin to Iron ratio on in-hospital prognosis of patients with COVID-19;Expert Review of Molecular Diagnostics;2022-03-15